glp-1 compounding news november 2025 weight loss drugs are back in the Societies take stand against off-brand

Recently, the GLP-1R agonist liraglutide was shown to ameliorate BLM-induced experimental lung fibrosis [26]

As relatively new drugs with huge potential to help treat our obesity crisis and an ever-growing list of indications, GLP-1s may be truly valuable even at the high price for a given individual

In contrast, another RCT found no significant differences in PASI or DLQI scores after 8 weeks of liraglutide treatment compared to placebo [18]

PubChem Compound Summary for CID 892, myo-Inositol

Starting your day with scrambled eggs and veggies can provide long-lasting energy while avoiding the nausea that sugary breakfasts sometimes cause